Research Topics
Species | J Kellogg ParsonsSummaryAffiliation: University of California Country: USA Publications
| Collaborators
|
Detail Information
Publications
Finasteride reduces the risk of incident clinical benign prostatic hyperplasiaJ Kellogg Parsons
Division of Urologic Oncology, Moores Comprehensive Cancer Center and Section of Urology, San Diego Veterans Affairs Medical Center, University of California, San Diego, La Jolla, CA 92093 0987, USA
Eur Urol 62:234-41. 2012..Despite the high prevalence of clinical benign prostatic hyperplasia (BPH) among older men, there remains a notable absence of studies focused on BPH prevention...
Complexed prostate-specific antigen for the diagnosis of biochemical recurrence after radical prostatectomyJ Kellogg Parsons
James Buchanan Brady Urological Institute, The Johns Hopkins Medical Institution, Baltimore, MD, USA
BJU Int 99:758-61. 2007..To determine the validity of using complexed prostate-specific antigen (cPSA) levels for diagnosing biochemical recurrence after radical prostatectomy (RP)...- Efficacy of alpha-blockers for the treatment of ureteral stonesJ Kellogg Parsons
Division of Urology, University of California San Diego School of Medicine, San Diego, California 92103, USA
J Urol 177:983-7; discussion 987. 2007..We determined if alpha-blocker therapy promotes expulsion of ureteral stones... - Dietary modification in patients with prostate cancer on active surveillance: a randomized, multicentre feasibility studyJ Kellogg Parsons
Moores Comprehensive Cancer Center, University of California San Diego, La Jolla, CA 21287, USA
BJU Int 101:1227-31. 2008..To evaluate the feasibility of implementing a diet-based intervention in men with prostate cancer on active surveillance, as changes in diet might potentially inhibit the progression of prostate cancer... - The Men's Eating and Living (MEAL) study: a Cancer and Leukemia Group B pilot trial of dietary intervention for the treatment of prostate cancerJ Kellogg Parsons
Moores Cancer Center, University of California San Diego, La Jolla, California, USA
Urology 72:633-7. 2008..To evaluate the feasibility of implementing a diet-based intervention in men with prostate cancer... - Epidemiologic issues in interstitial cystitisJ Kellogg Parsons
Division of Urology, Department of Surgery, University of California San Diego Medical Center, University of California, San Diego, San Diego, California 92103 8897, USA
Urology 69:5-8. 2007..Because IC is substantially underdiagnosed, its actual prevalence may be much higher. Indeed, the disease may affect as many as 1 in 4 to 5 women and 1 in 20 men... 
Metabolic factors associated with benign prostatic hyperplasiaJ Kellogg Parsons
Division of Urology, University of California San Diego, 200 West Arbor Drive, San Diego, California 21287, USA
J Clin Endocrinol Metab 91:2562-8. 2006..Obesity and associated abnormalities in glucose homeostasis may play a role in benign prostatic hyperplasia development by influencing prostate growth...- Dietary intervention after definitive therapy for localized prostate cancer: results from a pilot studyJ Kellogg Parsons
University of California, San Diego Medical Center, San Diego, CA 92103 8897, USA
Can J Urol 16:4648-54. 2009..Diet has been linked to prostate cancer risk. Dietary modification may inhibit prostate cancer progression... - Toxicity analysis of postoperative image-guided intensity-modulated radiotherapy for prostate cancerSameer K Nath
Department of Radiation Oncology, Rebecca and John Moores Comprehensive Cancer Center, University of California San Diego, La Jolla, USA
Int J Radiat Oncol Biol Phys 78:435-41. 2010..To report on the acute and late gastrointestinal (GI) and genitourinary (GU) toxicity associated with a unique technique of image-guided radiotherapy (IGRT) in patients undergoing postprostatectomy irradiation... - Obesity and prostate enlargement in men with localized prostate cancerRyan P Kopp
Division of Urology, Department of Surgery, UC San Diego Medical Center, CA, USA
BJU Int 108:1750-5. 2011..This study demonstrates an association between obesity and prostate enlargement in men with prostate cancer, and leads to possible implications for prostate cancer screening and diagnosis... - Inpatient safety trends in laparoscopic and open nephrectomy for renal tumoursSean P Stroup
UC San Diego Medical Center, Division of Urology VA San Diego Medical Center Moores UCSD Cancer Center, San Diego, CA 92103, USA
BJU Int 110:1808-13. 2012..This observation could have implications for patient safety in the setting of diffusion of new surgical techniques... - Serum sex hormones and the 20-year risk of lower urinary tract symptoms in community-dwelling older menMichael D Trifiro
Division of Urologic Oncology, Moores UCSD Cancer Center, San Diego, CA, USA
BJU Int 105:1554-9. 2010..To evaluate serum sex steroid hormone concentrations and long-term risk of subsequent lower urinary tract symptoms (LUTS) in a cohort of community-dwelling older men... - Trends in adverse events of benign prostatic hyperplasia (BPH) in the USA, 1998 to 2008Sean P Stroup
University of California San Diego UCSD, Division of Urology, San Diego, CA 92103 8897, USA
BJU Int 109:84-7. 2012..To determine if the adverse events (AEs) of benign prostatic hyperplasia (BPH) have declined in tandem with increased use of oral therapy... - Serum 25-hydroxyvitamin D and breast cancer in the military: a case-control study utilizing pre-diagnostic serumSharif B Mohr
Division of Epidemiology, Department of Family and Preventive Medicine, University of California San Diego, 9500 Gilman Drive 0620, La Jolla, CA 92093 0620, USA
Cancer Causes Control 24:495-504. 2013..The objective of this study was to ascertain whether a relationship exists between pre-diagnostic serum levels of 25-hydroxyvitamin D (25(OH)D) and risk of breast cancer in young women... - Progression of lower urinary tract symptoms in older men: a community based studyJ Kellogg Parsons
Division of Urologic Oncology, Moores Comprehensive Cancer Center, University of California San Diego, La Jolla, San Francisco, California, USA
J Urol 183:1915-20. 2010..Lower urinary tract symptom progression in community dwelling older men is not well described... - Prostate laser vaporization in men with urinary retentionJeffrey M Woldrich
Division of Urology, University of California San Diego Medical Center, San Diego, CA, USA
BJU Int 108:395-8. 2011..To evaluate the safety and efficacy of laser vaporization of the prostate (LVP) with several different wavelengths for urinary retention... - Obesity and benign prostatic hyperplasia: clinical connections, emerging etiological paradigms and future directionsJ Kellogg Parsons
Division of Urologic Oncology, Moores Cancer Center, University of California, San Diego, California, USA
J Urol 182:S27-31. 2009..Classic etiological paradigms for benign prostatic hyperplasia focus on nonmodifiable risk factors. However, obesity also potentially promotes benign prostatic hyperplasia... - Obesity and benign prostatic hyperplasia: clinical connections, emerging etiological paradigms and future directionsJ Kellogg Parsons
Division of Urologic Oncology, Moores Cancer Center, University of California San Diego and San Diego Veterans Affairs Medical Center, La Jolla, CA 92103, USA
J Urol 189:S102-6. 2013..Classic etiological paradigms for benign prostatic hyperplasia focus on nonmodifiable risk factors. However, obesity also potentially promotes benign prostatic hyperplasia... - Can a baseline prostate specific antigen level identify men who will have lower urinary tract symptoms later in life?H Ballentine Carter
Department of Urology, The Johns Hopkins University School of Medicine, Baltimore, Maryland, USA
J Urol 173:2040-3. 2005..We evaluated the relationship between baseline prostate specific antigen (PSA) and subsequent lower urinary tract symptom development during 3 decades in unselected men in the Baltimore Longitudinal Study of Aging... - Serum testosterone and the risk of prostate cancer: potential implications for testosterone therapyJ Kellogg Parsons
The James Buchanan Brady Urological Institute, The Johns Hopkins Hospital, Baltimore, MD 21287, USA
Cancer Epidemiol Biomarkers Prev 14:2257-60. 2005..We prospectively evaluated serum androgen concentrations and prostate cancer risk... - Lipids, lipoproteins and the risk of benign prostatic hyperplasia in community-dwelling menJ Kellogg Parsons
Division of Urology, Department of Surgery, University of California San Diego School of Medicine, La Jolla, CA 21287, USA
BJU Int 101:313-8. 2008..To examine the associations of serum lipids and lipoproteins with benign prostatic hyperplasia (BPH) in community-dwelling men... - Prostate size is not associated with recovery of sexual function after minimally invasive radical prostatectomyNicholas T Ward
Division of Urologic Oncology, Moores Comprehensive Cancer Center, University of California, San Diego, La Jolla, CA 92103 8897, USA
Urology 77:952-6. 2011..To investigate the association of prostate weight with recovery of sexual function after minimally invasive radical prostatectomy... - Applying complexed prostate-specific antigen to clinical practiceJ Kellogg Parsons
James Buchanan Brady Urological Institute, Johns Hopkins Medical Institutions, Baltimore, Maryland 21287, USA
Urology 63:815-8. 2004 - Monocyte chemotactic protein-1 (MCP-1/CCL2) is associated with prostatic growth dysregulation and benign prostatic hyperplasiaKazutoshi Fujita
The Brady Urological Institute, Johns Hopkins Medical Institutions, Baltimore, Maryland 21218, USA
Prostate 70:473-81. 2010..Cytokines are not only key mediators of inflammation but may also play important roles in the initiation and progression of BPH... - The first national examination of outcomes and trends in robotic surgery in the United StatesJamie E Anderson
Department of Surgery, University of California, San Diego, CA 92103, USA
J Am Coll Surg 215:107-14; discussion 114-6. 2012..There are few population-based data describing outcomes of robotic-assisted surgery. We compared outcomes of robotic-assisted, laparoscopic, and open surgery in a nationally representative population database... - Comprehensive mutational analysis and mRNA isoform quantification of TP63 in normal and neoplastic human prostate cellsJ Kellogg Parsons
Division of Urology, University of California, San Diego Medical Center, San Diego, California, USA
Prostate 69:559-69. 2009..Since a complex array of TP63 mRNA transcripts encode polypeptides with distinct functional properties, it is important to determine which forms are expressed in normal and prostate cancer tissue... - Hand-assisted and total laparoscopic nephrectomy: a comparisonJonathan Silberstein
University of California, San Diego Medical Center, San Diego, California, USA
JSLS 13:36-43. 2009..Debate continues as to the merits of hand-assisted versus pure laparoscopic nephrectomy. Using evidence-based analysis, we compared the outcomes of both... - Prevalence and characteristics of lower urinary tract symptoms in men aged > or = 80 yearsJ Kellogg Parsons
Division of Urology, University of California, San Diego, Medical Center, San Diego, California 92103 8897, USA
Urology 72:318-21. 2008..We analyzed the prevalence and characteristics of lower urinary tract symptoms (LUTS) in community-dwelling men aged 80 years and older... - Outcomes of retropubic, laparoscopic, and robotic-assisted prostatectomyJ Kellogg Parsons
Division of Urology, University of California San Diego School of Medicine, San Diego, California 21287, USA
Urology 72:412-6. 2008..To compare outcomes of radical retropubic, laparoscopic, and robotic-assisted prostatectomy using evidence-based analysis... - Local anesthetic reduces pain associated with transrectal ultrasound-guided prostate biopsy: a meta-analysisLori Hergan
Division of Urology, University of California, San Diego, School of Medicine, San Diego, California 92103 8897, USA
Urology 69:520-5. 2007..To determine whether local anesthetic decreases the pain associated with transrectal ultrasound-guided prostate needle biopsy... - Clinical interpretation of prostate biopsy reportsJ Kellogg Parsons
James Buchanan Brady Urological Institute, Johns Hopkins Medical Institutions, Baltimore, Maryland, USA
Urology 67:452-7. 2006 - Prospective study of serum dihydrotestosterone and subsequent risk of benign prostatic hyperplasia in community dwelling men: the Rancho Bernardo StudyJ Kellogg Parsons
Division of Urologic Oncology, Moores University of California San Diego Cancer Center, La Jolla, California, USA
J Urol 184:1040-4. 2010..Little is known about midlife serum levels of dihydrotestosterone and other androgens before the onset of clinical benign prostatic hyperplasia in community dwelling older men... - Incidence and prevention of iatrogenic urethral injuriesCarol Kashefi
Division of Urology, University of California San Diego School of Medicine, San Diego, California 92103, USA
J Urol 179:2254-7; discussion 2257-8. 2008..We studied the incidence and mechanism of iatrogenic urinary catheter injuries occurring in adult male inpatients at a single institution. We also designed and implemented an intervention to prevent these injuries... - Evidence-based principles of bladder cancer and dietJonathan L Silberstein
Division of Urology, Department of Surgery, University of California, San Diego Medical Center, San Diego, CA 92103 8897, USA
Urology 75:340-6. 2010.... - Lower urinary tract symptoms increase the risk of falls in older menJ Kellogg Parsons
Department of Surgery, Division of Urology, University of California, San Diego, CA, USA
BJU Int 104:63-8. 2009..Because of the serious consequences of falls, these results might justify the routine assessment of LUTS with a validated questionnaire in the primary care of this population... - Prostate bed localization with image-guided approach using on-board imaging: reporting acute toxicity and implications for radiation therapy planning following prostatectomyAjay Sandhu
Department of Radiation Oncology, Division of Urology and Medical Oncology, University of California, San Diego Medical Center, La Jolla, CA 92093 0843, USA
Radiother Oncol 88:20-5. 2008..To report our experience using Image-Guided Radiation Therapy (IGRT) in patients undergoing post-prostatectomy irradiation... - Physical activity, benign prostatic hyperplasia, and lower urinary tract symptomsJ Kellogg Parsons
Division of Urology, Department of Surgery, University of California, San Diego School of Medicine, La Jolla, CA 92103 8897, USA
Eur Urol 53:1228-35. 2008..While some studies have indicated that physical activity may protect against benign prostatic hyperplasia (BPH) and lower urinary tract symptoms (LUTS), others have not... - Effect of methylprednisolone on return of sexual function after nerve-sparing radical retropubic prostatectomyJ Kellogg Parsons
James Buchanan Brady Urological Institute, Johns Hopkins Medical Institutions, Baltimore, Maryland 21287, USA
Urology 64:987-90. 2004.... - Complications of abdominal urologic laparoscopy: longitudinal five-year analysisJ Kellogg Parsons
James Buchanan Brady Urological Institute, Johns Hopkins Medical Institutions, Baltimore, Maryland, USA
Urology 63:27-32. 2004..This experience may represent the average complication rate for urologic laparoscopy at a large-volume, academic training center... - Patient safety and the diffusion of surgical innovations: a national analysis of laparoscopic partial nephrectomyJ Kellogg Parsons
Division of Urology, UC San Diego Medical Center, San Diego, CA, USA
Surg Endosc 27:1674-80. 2013..Laparoscopic partial nephrectomy (LPN) provides an apt model for population-based analyses of patient safety and the propagation of complex surgical innovations... - Combination pharmacological therapies for the management of benign prostatic hyperplasiaSeth A Cohen
Division of Urology, UC San Diego Medical Center, San Diego, CA 92103 8897, USA
Drugs Aging 29:275-84. 2012.... - Management of pelvic lymphoceles following robot-assisted laparoscopic radical prostatectomyOmer A Raheem
Department of Surgery, Division of Urology, University of California, San Diego Medical Center, San Diego, USA
Urol Ann 4:111-4. 2012..We report our experience with management of clinically symptomatic pelvic lymphoceles following robotic-assisted prostatectomy using laparoscopic marsupialization... - Serum 25-hydroxyvitamin D and prevention of breast cancer: pooled analysisSharif B Mohr
Department of Family and Preventive Medicine, University of California San Diego, 9500 Gilman Drive 0620, La Jolla, CA 92093 0620, USA
Anticancer Res 31:2939-48. 2011..Since publication of the most current meta-analysis of 25(OH)D and breast cancer risk, two new nested case-control studies have emerged... - Alcohol consumption is associated with a decreased risk of benign prostatic hyperplasiaJ Kellogg Parsons
Department of Surgery, Division of Urologic Oncology, Moores Comprehensive Cancer Center, University of California San Diego and VA Medical Center San Diego, La Jolla, California 92103 8897, USA
J Urol 182:1463-8. 2009..We evaluated associations of alcohol consumption with benign prostatic hyperplasia and male lower urinary tract symptoms... - Prostate cancer treatment for economically disadvantaged men: a comparison of county hospitals and private providersJ Kellogg Parsons
Moores Comprehensive Cancer Center, University of California, La Jolla, CA, USA
Cancer 116:1378-84. 2010..The authors compared the types of treatments prostate cancer patients received from county hospitals and private providers as part of a statewide public assistance program... - Modifiable risk factors for benign prostatic hyperplasia and lower urinary tract symptoms: new approaches to old problemsJ Kellogg Parsons
Division of Urology, University of California San Diego School of Medicine, San Diego, California 92103 8897, USA
J Urol 178:395-401. 2007..Benign prostatic hyperplasia is generally not regarded as a preventable disease. However, accumulating evidence suggests that modifiable factors may influence the risk of benign prostatic hyperplasia and lower urinary tract symptoms... - The effect of previous abdominal surgery on urological laparoscopyJ Kellogg Parsons
The Brady Urological Institute, The Johns Hopkins Medical Institutions, Baltimore, Maryland, USA
J Urol 168:2387-90. 2002..Therefore, previous abdominal surgery does not appear to affect adversely the performance of subsequent urological laparoscopy... - Infundibular stenosis after percutaneous nephrolithotomyJ Kellogg Parsons
Brady Urological Institute, The Johns Hopkins Medical Institutions, Baltimore, MD, USA
J Urol 167:35-8. 2002..Mild and moderate cases may be treated with observation and endoscopic dilation, respectively, while severe cases may result in renal impairment... - Laparoscopic pyeloplasty with concomitant pyelolithotomySanjay Ramakumar
Section of Urology, Department of Surgery, University of Arizona, Tucson, Arizona, USA
J Urol 167:1378-80. 2002..Our results are comparable to those of stone removal during open pyeloplasty or percutaneous endopyelotomy. The advantages of open surgery appear to be maintained in this minimally invasive approach... - Vaginal reconstruction utilizing sigmoid colon: Complications and long-term resultsJ Kellogg Parsons
Division of Pediatric Urology, The James Buchanan Brady Urological Institute, Department of Surgery, The Johns Hopkins Hospital, The Johns Hopkins University School of Medicine, Baltimore, MD, USA
J Pediatr Surg 37:629-33. 2002..For the best long-term results, a multidisciplinary team must be available from infancy to supply comprehensive support... - The historical origins of interstitial cystitisJ Kellogg Parsons
Brady Urological Institute, Johns Hopkins Medical Institutions, Baltimore, Maryland 21287, USA
J Urol 171:20-2. 2004..We identify early descriptions of interstitial cystitis and trace its evolution as a clinical entity during the 19th century... - Urinary stone size: comparison of abdominal plain radiography and noncontrast CT measurementsJ Kellogg Parsons
James Buchanan Brady Urological Institute, The Johns Hopkins Medical Institutions, Baltimore, Maryland 21287-2101, USA
J Endourol 17:725-8. 2003..As AXRs are more expeditiously obtained, incur less direct costs, and expose patients to significantly lower doses of radiation than CT scans, they remain a useful adjunctive study in the work-up of nephrolithiasis... - Complexed prostate specific antigen (PSA) reduces unnecessary prostate biopsies in the 2.6-4.0 ng/mL range of total PSAJ Kellogg Parsons
The James Buchanan Brady Urological Institute, The Johns Hopkins Medical Institutions Baltimore, MD 21287, USA
BJU Int 94:47-50. 2004..To compare the performance of complexed prostate-specific antigen (cPSA) to total PSA (tPSA) and percentage free PSA (f/tPSA) in the diagnosis of prostate cancer for the tPSA range 2.6-4.0 ng/mL... - Hugh Hampton Young, benign prostatic hyperplasia, and "the cure of prostatic obstruction"J Kellogg Parsons
J Am Coll Surg 201:654-5. 2005 - Commentary on BPH and public health--have we lost the forest through the trees?J Kellogg Parsons
J Urol 179:S81. 2008